Related Experiment Videos
ABO aggulutinins from Biomphalari straminea snails
Summary
Extracts from B. straminea spawn show activity against normal A and B red blood cells. Specific enzyme treatments allow differentiation of A1 and A2 subgroups, with some reactions observed with O cells.
Area of Science:
- Immunology
- Biochemistry
- Hematology
Background:
- Blood group antigens are crucial for transfusion compatibility.
- Understanding the reactivity of biological extracts with red blood cells is important for serological investigations.
- The B. straminea spawn extract's potential as a serological reagent requires characterization.
Purpose of the Study:
- To investigate the activity of B. straminea spawn extracts against human red blood cells.
- To determine if these extracts can differentiate between ABO blood groups and subgroups.
- To assess the effect of enzymatic treatment on red blood cell reactivity with the extracts.
Main Methods:
- Preparation of extracts from B. straminea spawn.
- Testing extract reactivity against normal A, B, and O red blood cells.
- Enzymatic treatment of red blood cells (trypsin, papain, pronase, neuraminidase) prior to testing.
- Observation and recording of agglutination reactions.
Main Results:
- B. straminea spawn extracts demonstrated activity against normal A and B red blood cells.
- The extracts successfully differentiated between A1 and A2 subgroups when used with enzyme-treated cells.
- O cells treated with papain, pronase, and neuraminidase showed weak reactions with the extracts.
Conclusions:
- B. straminea spawn extracts possess specific agglutinating properties relevant to human red blood cells.
- Enzymatic treatment enhances the utility of these extracts for differentiating A1 and A2 subgroups.
- Further research may establish B. straminea spawn extracts as valuable tools in blood grouping and serology.